首页>Arteriosclerosis, thrombosis, and vascular biology>Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction
Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction
作者单位:Department of Medicine, Emory University School of Medicine, 101 Woodruff Circle WMB 319B, Atlanta[1]CV Path Institute, Inc, Gaithersburg, MD, United States[2]